← Back
Cavalieri II Room
December, 02nd | 10:45 - 12:10
WET AMD: TREATMENT
Add to calendar
Chairs: BRESSLER SUSAN, HOLZ FRANK, KOROBELNIK JEAN-FRANCOIS
December, 02nd | 10:45 - 10:51
Falls and AMD: What Ophthalmologists Might Want to Know
BRESSLER SUSAN
Add to calendar
Falls and AMD: What Ophthalmologists Might Want to Know
BRESSLER SUSAN
Add to calendar
December, 02nd | 10:51 - 10:57
Characteristics and outcome of wet AMD with good visual acuity (>20/40)
CHHABLANI JAY
Add to calendar
Characteristics and outcome of wet AMD with good visual acuity (>20/40)
CHHABLANI JAY
Add to calendar
December, 02nd | 10:57 - 11:03
The DRCR Retina Network enters the field of AMD
JAMPOL LEE MERRILL
Add to calendar
The DRCR Retina Network enters the field of AMD
JAMPOL LEE MERRILL
Add to calendar
December, 02nd | 11:03 - 11:09
Relevance of drug dynamics in the treatment of neovascular AMD: Modeling and animal studies
LANZETTA PAOLO
Add to calendar
Relevance of drug dynamics in the treatment of neovascular AMD: Modeling and animal studies
LANZETTA PAOLO
Add to calendar
December, 02nd | 11:09 - 11:15
Real-Life Data in the Treatment of Neovascular AMD: Results from the Imaculaweb Registry Evaluated in a Single Italian Medical Retina Center
NICOLÓ MASSIMO
Add to calendar
Real-Life Data in the Treatment of Neovascular AMD: Results from the Imaculaweb Registry Evaluated in a Single Italian Medical Retina Center
NICOLÓ MASSIMO
Add to calendar
December, 02nd | 11:15 - 11:21
Brolucizumab 3 years experience in wet AMD
STAURENGHI GIOVANNI
Add to calendar
Brolucizumab 3 years experience in wet AMD
STAURENGHI GIOVANNI
Add to calendar
December, 02nd | 11:21 - 11:27
Early Treatment Patterns and Outcomes in Patients With Neovascular Age Related Macular Degeneration Initiating Faricimab: The FARETINA-AMD Study
LENG THEODORE
Add to calendar
Early Treatment Patterns and Outcomes in Patients With Neovascular Age Related Macular Degeneration Initiating Faricimab: The FARETINA-AMD Study
LENG THEODORE
Add to calendar
December, 02nd | 11:27 - 11:33
New strategies for new treatments in AMD
KOROBELNIK JEAN-FRANCOIS
Add to calendar
New strategies for new treatments in AMD
KOROBELNIK JEAN-FRANCOIS
Add to calendar
December, 02nd | 11:33 - 11:39
Real-World Data (RWD) and Initial Pharmacodynamics of Faricimab in Patients with Neovascular Age-Related Macular Degeneration (nAMD).
ZWEIFEL SANDRINE
Add to calendar
Real-World Data (RWD) and Initial Pharmacodynamics of Faricimab in Patients with Neovascular Age-Related Macular Degeneration (nAMD).
ZWEIFEL SANDRINE
Add to calendar
December, 02nd | 11:39 - 11:45
Results from the TRUCKEE study: real world experience with faricimab for neovascular AM
SADDA SRINIVAS
Add to calendar
Results from the TRUCKEE study: real world experience with faricimab for neovascular AM
SADDA SRINIVAS
Add to calendar
December, 02nd | 11:45 - 11:51
Intravitreal aflibercept 8 mg injection in patients with neovascular age-related macular degeneration: 2-year results from the Phase 3 PULSAR trial
HOLZ FRANK
Add to calendar
Intravitreal aflibercept 8 mg injection in patients with neovascular age-related macular degeneration: 2-year results from the Phase 3 PULSAR trial
HOLZ FRANK
Add to calendar
December, 02nd | 11:57 - 12:03
Subretinal Delivery of ABBV-RGX-314 for Neovascular AMD: A Phase II Pharmacodynamic Study
HO ALLEN
Add to calendar
Subretinal Delivery of ABBV-RGX-314 for Neovascular AMD: A Phase II Pharmacodynamic Study
HO ALLEN
Add to calendar
